Vanessa Froese will be the new Head of Marketing & Sales, Dr. Torsten Horns will join as Head of the newly created Business Development Segment.

Cytolon AG and T-Cell Europe GmbH (TCell) announced their cooperation today. TCell will start using Cytolon´s IT-matching-system CordMatch^® for all its allogenic T-cell products.

Cytolon AG announced a further strategic development of its CordMatch^® platform: the Distributed-Inventory-TechnologyTM.

Cytolon AG has joined the Personalized Medicine Coalition, PMC. The education and advocacy organization PMC is representing scientists, patients, providers and payers to promote the understanding and adoption of personalized...

Cytolon AG has successfully completed its second financing round acquiring a multi-million euro investment in the company.

Cytolon has acquired a patent in Australia for the IT-Matching Platform CordMatch^® as part of the ongoing applications for a series of patents.

Cytolon has gained DKMS Cord Blood Bank as a partner for the important beta-testing phase of CordMatch^®. The DKMS Cord Blood Bank is a 100% owned subsidiary of the DKMS German Bone Marrow Donor Registry GmbH, the largest stem...

Cytolon AG announced today that Dr.Timm Jessen has been appointed to the company´s Supervisory Board.

Berlin, December 16th 2010 - Cytolon AG announced today the signing of an agreement with iSoft to integrate its AccelFind solution, developed by US-based CliniWorks, with its platform CordMatch^®. CordMatch^® is a unique, web-based...

Berlin, November 3rd 2010 - Cytolon AG announced today that Michaela Servas has accepted an appointment to the company´s Supervisory Board.  Michaela Servas is an entrepreneur from the Healthcare sector who brings to Cytolon...

Berlin, November 2nd 2010 – Professor Joachim Wolfram Dudenhausen, co-founder and member of Cytolon´s Supervisory Board and Scientific Advisory Board, received today an Order of Merit of the Federal Republic of Germany.Dr....

Berlin, June 24th 2010 - Cytolon AG announced today going live with the release 1.0 of the CordMatch^® platform.  After 18 months of market research and hundreds of interviews with health care professionals from...

Berlin, January 29, 2010 – Cytolon AG announced today the signing of an agreement with CSC for the rapid development of Cytolon's CordMatch^® platform. This platform will enable patients who need transplantation to get the...

Berlin, December 15th, 2009 – Cytolon AG announced today the successful closing of its A-series financing round with institutional and private investors. Details of the transaction have not been disclosed. This investment...

Berlin, December 2nd 2009 – Cytolon AG announced today that Wolfgang Jünger has accepted an appointment to the company's Supervisory Board. Wolfgang Jünger is an entrepreneur, management consultant and investor. He has been...

Berlin, November 12th 2009 – Cytolon AG announced today that Katherina Reiche, MdB, has resigned as a member of the Company's Supervisory Board after her appointment as a member of the Federal Government of Germany as...

Awarded by Hasso Plattner Ventures, Deutsche Bank, Deutsche Telekom and MAN Ferrostaal Berlin, June 30th, 2009 – Cytolon AG announced today that Founder and Chief Executive Officer Thomas Klein received the "MOST...

Berlin, November 17th 2008 – Cytolon AG announced today that it has entered into a cooperative agreement with ARCWAY AG regarding the development and market research of the specifications for the Cytolon's CordMatch^® platform,...

Dr. Jürgen Schumacher, co-founder of Qiagen, is a Leading Investor Berlin, October 31st 2008 – Cytolon AG announced today the closing of their start-up financing, with the amount and conditions of the investment not...

Berlin, April 14th, 2008 – Thomas Klein, principal founder and Chief Executive Officer, is pleased to announce the launching of Cytolon AG, a private company based in Berlin, Germany that has developed a proprietary,...